FSSAI Suspends License of Dior Pharmaceuticals Over Critical Violations at Nutraceutical Manufacturing Unit

The Food Safety and Standards Authority of India (FSSAI) has officially suspended the manufacturing license of Dior Pharmaceuticals...

JP Nadda Urges Bengal MPs to Join the Fight Against TB

Union Health Minister J.P. Naddamet with West Bengal's Members of Parliament in New Delhi on Wednesday, urging cross-party lawmakers...

FSSAI Suspends License of Dior Pharmaceuticals Over Critical Violations at Nutraceutical Manufacturing Unit

The Food Safety and Standards Authority of India (FSSAI) has officially suspended the manufacturing license of Dior Pharmaceuticals with immediate effect, following a comprehensive regulatory inspection that uncovered major...

JP Nadda Urges Bengal MPs to Join the Fight Against TB

Union Health Minister J.P. Naddamet with West Bengal's Members of Parliament in New Delhi on Wednesday, urging cross-party lawmakers to spearhead grassroots efforts against tuberculosis in their constituencies. The session,...

DCGI Approves Qdenga, Marking India’s First Dengue Vaccine

 Takeda Biopharmaceuticals India has received market authorisation from the Drug Controller General of India (DCGI) for Qdenga, making it...

NATCO Gets USFDA Nod for Generic Cancer Drug Olaparib

Alembic Pharmaceuticals Limited announced that its development partner, NATCO Pharma Limited (NATCO), has received tentative approval from the...

Lupin Earns Great Place To Work® India 2026 Nation Builders Recognition

Lupin Limited (Lupin)  announced that it has been recognized among India's Best Employers in the Nation-Builders Category 2026 by...

Government Reviews Ayushman Bharat, Plans Next Phase of Healthcare Reforms

The National Health Authority concluded its two-day Chintan Shivir on Ayushman Bharat PM-JAY and the Ayushman Bharat Digital Mission, held July 17–18, 2026, in New...

Eli Lilly Acquires AtaiBeckley to Accelerate Innovative Depression Treatments

Eli Lilly and Company  and AtaiBeckley Inc.  announced a...

AstraZeneca Licenses Novel Lung Cancer Drug Zegfrovy in $1.5B Global Deal

AstraZeneca  announced a exclusive global license agreement with Dizal Pharmaceutical to...

DONT MISS

Trending NOW

Most Popular

​OneSource Partners with Germany’s Formycon AG to Produce Biosimilars for Global Markets

OneSource Speciality Pharma has entered into a strategic manufacturing...

CDSCO Issues Final Guidance for Medical Device Software Under MDR 2017

The Central Drugs Standard Control Organisation (CDSCO), functioning under...

EMeRG Launches Hospital Intel Suite™️ to transform MedTech Market

EMeRG, a leading healthcare intelligence provider with over a...

CDSCO Partners with THSTI to Strengthen Vaccine and Healthcare innovation

The Central Drugs Standard Control Organization (CDSCO), India’s national...

Emcure Pharma Receives CDSCO Approval to Launch Poviztra®️ for Fatty Liver Disease Treatment

Emcure Pharmaceuticals Ltd  announced that its co-marketed semaglutide brand,...

Bhawanipur Global Campus Announces iNATCONPH 2026: A Global Platform for Pharmacy & Allied Health Research

Kolkata: Bhawanipur Global Campus has announced the 16th International...

Momentis Surgical’s Anovo Robotic System Gets FDA Approval for Multiport Surgery

Momentis Surgical has secured 510(k) clearance from the U.S. Food...

General News

JP Nadda Urges Bengal MPs to Join the Fight Against TB

Union Health Minister J.P. Naddamet with West Bengal's Members of...

AstraZeneca reports Mixed Phase III Results for Ultomiris in Rare Post-Transplant Blood Disorder

AstraZeneca's Alexion unit has reported divergent outcomes from its...

Cipla Receives U.S. FDA Approval for Generic Advair Diskus®️

Cipla Limited and its wholly owned subsidiary, Cipla USA Inc., have received...

Government of Andhra Pradesh Partners to Launch AI and Genomic-Powered 360-Degree Oncology Care Model

The Government of Andhra Pradesh has announced a strategic...

Become a member

Dose Daily News is your trusted source for the latest updates in healthcare and pharmaceuticals. We deliver clear, reliable, and timely news to keep you informed and ahead in the world of health and medicine.

Drug Approvals

AstraZeneca reports Mixed Phase III Results for Ultomiris in Rare Post-Transplant Blood Disorder

AstraZeneca's Alexion unit has reported divergent outcomes from its...

​Zydus Collaborates with ICMR to Address Sickle Cell Disease as Desidustat Enters Phase III

Zydus Lifesciences Limited, in collaboration with the Indian Council of...

Emcure Pharma Receives CDSCO Approval to Launch Poviztra®️ for Fatty Liver Disease Treatment

Emcure Pharmaceuticals Ltd  announced that its co-marketed semaglutide brand,...

DCGI Approves Qdenga, Marking India’s First Dengue Vaccine

 Takeda Biopharmaceuticals India has received market authorisation from the...

NATCO Gets USFDA Nod for Generic Cancer Drug Olaparib

Alembic Pharmaceuticals Limited announced that its development partner, NATCO...

Pharma Edupoint

CISCE Makes Health and Physical Education Compulsory for Classes 9 to 12 Under NEP 2020

The Council for the Indian School Certificate Examinations (CISCE)...

NCAHP Launches Competency-Based DMLT Curriculum to Update India’s Allied Healthcare Education

The National Commission for Allied and Healthcare Professions (NCAHP),...

Sports Injury Centre and SAI Sign Landmark MoU for Athlete Care

In a major boost to the nation’s sports ecosystem,...

Top 15 Pharmacy Colleges in West Bengal: Complete Guide for Pharmacy Aspirants (2026)

Choosing the right pharmacy college is one of the...

New Hope for Neuro care: Lupin Opens “Atharv” An Advanced Ability Center in Delhi

Lupin has inaugurated Atharv Ability, an advanced multidisciplinary neuro-rehabilitation center...

Career & Exams

West Bengal to Set up three New Medical college with 300 total MBBS set

The Government of West Bengal has officially initiated the...

Top 15 Pharmacy Colleges in West Bengal: Complete Guide for Pharmacy Aspirants (2026)

Choosing the right pharmacy college is one of the...

FDA Approves Datroway for Metastatic Triple-Negative Breast Cancer

AstraZeneca and Daiichi Sankyo  announced that the US Food and Drug...

West Bengal Pharmacy Council Announces Online Registration Renewal from August 1, 2026

The West Bengal Pharmacy Council has announced the introduction of an...

UGC-NET 2026 Expansion: Statistics Entry Set to Power Healthcare Analytics, Epidemiology & Medical Research Careers

In a significant academic reform with far-reaching implications for...

AI in Healthcare

Event Now

Global Health

Career & Exam

Latest Articles

Bristol Myers Squibb Secures Dual Regulatory Wins for Opdivo® in Classical Hodgkin Lymphoma

Bristol Myers Squibb (NYSE: BMY) announced that Opdivo® (nivolumab) has received approval for two new classical Hodgkin Lymphoma (cHL) indications in the U.S. and...

Lupin Secures ANDA Approval, Set to Enter the Chinese Market

Indian global pharma giant on 22 May, though a press release has announced that the company has received the China's National Medical Products Administration’s (NMPA) approval of Abbreviated New Drug Application (ANDA) for its Oseltamivir...

Alembic Receives USFDA Approval for Levothyroxine Sodium Tablets

Alembic Pharmaceuticals Limited  announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application...

Commitment Towards Precise Diagnostic Services: Metropolis Healthcare Launches New Greenfield Laboratoryin Panjab

On 22nd May 2026, the Metropolis Healthcare, one of Indias leading diagnostics chain launches their new “Greenfield Laboratory” in Panjab’s Amritsar. The inauguration was graced by Dr. Anumeet Singh Grover, renowned gastroenterologist along with other renowned medical professionals across the country and...

FDA Approves Datroway for Metastatic Triple-Negative Breast Cancer

AstraZeneca and Daiichi Sankyo  announced that the US Food and Drug Administration (FDA) has approved Datroway(datopotamab deruxtecan) for adult patients with unresectable or metastatic triple-negative breast cancer (TNBC)...

Medicare Now Covers Obesity Drugs: Affordable GLP-1 Access Begins

In a landmark shift for American healthcare, Medicare has begun covering GLP-1 medications — including semaglutide (Wegovy) and tirzepatide(Zepbound) — for patients with obesity and related conditions,...

Subscribe